Prospective study of correlation between prognosis and quantitative detection of circulating tumor cell (CTC) in peripheral blood from patients with gastric cancer

Prospective study of correlation between prognosis and quantitative detection of circulating tumor cell (CTC) in peripheral blood from patients with gastric cancer - Prognosis and quantitative detection of circulating tumor cell (CTC) in blood from patients with gastric cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002018

Enrollment

150

Registered

2009-05-29

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Measurement of circulating tumor cell (CTC) in peripheral blood from patients with gastric cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastric cancer patient Informed consent

Exclusion criteria

Exclusion criteria: Association of malignant neoplasms of other organs

Design outcomes

Primary

Measure	Time frame
measured value of circulating tumor cell (CTC)in peripheral blood, overall survival and relapse-free survival	—

Secondary

Measure	Time frame
Tumor clinical factor, tumor pathological factor and patients background	—

Countries

Japan

Contacts

Public ContactHiroaki Ito, MD, PhD

Showa University Nothern Yokohama Hospital Digestive Disease Center

h.ito@med.showa-u.ac.jp045-949-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026